Is there any rationale for using both deutetrabenazine (Austedo) and valbenazine (Ingrezza) at the same time? Find out from Psych Congress cochair Rakesh Jain, MD, MPH.READ MORE
Greater depressive and anxiety symptoms at baseline predicted a better response to treatment with synchronized transcranial magnetic stimulation (sTMS) for major depressive disorder (MDD), according to a study.READ MORE
A nationwide study in Denmark suggests a link between infections in childhood and adolescence and increased risk of subsequent mental disorders.READ MORE
Neonatal vitamin D deficiency is associated with a 44% increased risk of schizophrenia later in life, according to a study published in Scientific Reports.READ MORE
Adjunctive testosterone treatment in men is associated with a significant drop in depressive symptoms, compared with placebo, according to a systematic review and meta-analysis published online in JAMA Psychiatry.READ MORE
Psych Congress Year-Round
ORLANDO, Fla.—Patients with generalized anxiety disorder (GAD) typically live with symptoms for more than 10 years before seeking treatment, Pratap R. Chokka, MD, FRCPC, told attendees at Psych Congress 2018.
ORLANDO, Fla.—A friendly debate between 2 thought leaders followed by a vote at Psych Congress 2018 exhibited the divide that persists on a controversial topic in mental health: whether antidepressants should be used to treat patients with bipolar depression.